Biotech Values

[DewDiligence]

ANDS: Here’s the formatted table from today’s PR.
Note that all trial arms included interferon+ribavirin.

 
                    All Patients    Genotype-1a     Genotype-1b  
                   ANA598 Placebo  ANA598 Placebo  ANA598 Placebo  
 No. of patients    27      15      20      12        7      3 
  
 RVR                56%     20%     50%     17%      71%    33%  
  
 Mean log VL 
 decline @week 4    4.1     2.7     4.2     2.4      3.7    3.9